<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04134156</url>
  </required_header>
  <id_info>
    <org_study_id>Mansoura105</org_study_id>
    <nct_id>NCT04134156</nct_id>
  </id_info>
  <brief_title>Sleeve Gastrectomy Versus One-anastomosis Gastric Bypass: Randomized Trial</brief_title>
  <official_title>Weight Loss and Change in Ghrelin and GLP-1 Levels After Sleeve Gastrectomy and One-anastomosis Gastric Bypass: a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hormonal changes after SG and OAGB involve alterations in the levels of many enteric&#xD;
      hormones, among these hormones are ghrelin and glucagon-like peptide-1 (GLP-1). Ghrelin is an&#xD;
      orexigenic hormone that stimulates food intake and has a documented role in the development&#xD;
      of obesity. While ghrelin levels decrease significantly after SG as the fundus, which is the&#xD;
      main source of that hormone, is completely removed, they tend to increase after OAGB GLP-1&#xD;
      plays an important role in glucose homeostasis via affecting food intake and satiety. It&#xD;
      enhances insulin secretion, stimulates the proliferation and growth of pancreatic beta cells,&#xD;
      inhibits food and water intake, and promotes satiety. Some studies reported that both OAGB&#xD;
      and SG are followed by increased GLP-1 levels. We conducted this randomized study to compare&#xD;
      SG and OAGB with regards to weight loss, comorbidity resolution, changes in ghrelin and GLP-1&#xD;
      hormones, and complications.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date type="Actual">March 1, 2016</start_date>
  <completion_date type="Anticipated">November 1, 2019</completion_date>
  <primary_completion_date type="Actual">December 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>excess weight loss</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>the percentage of excess weight loss after surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>Sleeve gastrectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5-port standard sleeve gastrectomy was conducted</description>
  </arm_group>
  <arm_group>
    <arm_group_label>one anastomosis gastric bypass</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5-port standard one-anastomosis gastric bypass was performed</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sleeve gastrectomy</intervention_name>
    <description>5-port sleeve gastrectomy</description>
    <arm_group_label>Sleeve gastrectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>one anastomosis gastric bypass</intervention_name>
    <description>5-port one anastomosis gastric bypass</description>
    <arm_group_label>one anastomosis gastric bypass</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients of both genders with morbid obesity (defined as BMI &gt; 40 kg/m2 or &gt; 35&#xD;
             Kg/m2 with at least one associated comorbidity) were included. Patients who underwent&#xD;
             previous surgery for morbid obesity were also included.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients ageing more than 60 years&#xD;
&#xD;
          -  patients with endocrine disorders&#xD;
&#xD;
          -  patients with psychiatric disorders that influence perception of the study protocol&#xD;
&#xD;
          -  patients unfit for general anesthesia.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mansoura university hospital</name>
      <address>
        <city>Mansourah</city>
        <state>Dakahlia</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 18, 2019</study_first_submitted>
  <study_first_submitted_qc>October 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2019</study_first_posted>
  <last_update_submitted>October 18, 2019</last_update_submitted>
  <last_update_submitted_qc>October 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Sameh Emile</investigator_full_name>
    <investigator_title>Lecturer of surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

